lysergic acid diethylamide has been researched along with Glial Cell Tumors in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MacDermot, J | 2 |
Higashida, H | 2 |
Wilson, SP | 1 |
Matsuzawa, H | 1 |
Minna, J | 1 |
Nirenberg, M | 1 |
2 other studies available for lysergic acid diethylamide and Glial Cell Tumors
Article | Year |
---|---|
Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Line; Cell Transformation, Vir | 1979 |
Independent regulation of receptor-mediated cell depolarization and adenylate cyclase by 5-hydroxytryptamine (serotonin) in neuroblastoma hybrid cells [proceedings].
Topics: Adenylyl Cyclases; Animals; Cell Line; Glioma; Hybrid Cells; Lysergic Acid Diethylamide; Mice; Neuro | 1979 |